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Abstract.  AHNAK is a newly identified human gene 
notable for the exceptional size (c.a.  700 kD) and 
structure of its product, and for the repression of its 
expression in human neuroblastoma cells. Here we re- 
port the identification and partial characterization of 
the protein encoded by AHNAK. The protein is lo- 
cated principally  (but not exclusively) in the nucleus 
and is phosphorylated on both serine and threonine. 
The abundance of the protein increases appreciably 
when cells withdraw from the division cycle, in re- 
sponse to either withdrawal of serum (fibroblasts) or 
differentiation (neuroblastorna cells). By contrast,  the 
amount of phosphorylation appears to diminish  in 
those settings.  The considerable abundance and con- 
jectured fibrous structure of AHNAK protein suggest a 
role in cytoarchitecture, but no function can yet be 
discerned. 
W 
E have described previously the identification  of a 
human gene,  AHNAK, that  appears to encode a 
protein of exceptional size (c.a. 700 kD) and struc- 
ture (7).  AHNAK was first encountered as one of a group 
of eDNA clones isolated through subtractive cloning on the 
basis of differential expression in human tumors of neuroec- 
todermal  origin (6).  Another eDNA clone from the sub- 
traeted eDNA library was identified  as CD44, the integral 
membrane glyeoprotein implicated in a variety of specific 
cell-cell and cell-matrix interactions  (6). Both AHNAK and 
CD44 are expressed in melanoma and pheochromocytoma but 
are repressed in neuroblastoma cell lines. 
Our interest in AHNAK was prompted by the following 
observations.  First, we have documented a pattern of coordi- 
nated expression of AHNAK and CIM4 in different human 
cell lineages  (6, 7).  This may indicate  that both genes are 
subject to the same transcriptional  regulation,  leading to the 
suppression of their expression in neuroblastoma cell lines. 
Analysis of this regulation  might reveal factors involved in 
the pathogenesis  of neuroblastoma. Second, our analysis of 
AHNAK revealed that its predicted protein product has an 
unprecedented secondary structure,  suggesting  that it may 
fulfill a novel function in the cell. The possible importance 
of this function is reflected in the apparent phylogenetic con- 
servation  of AHNAK sequences (7). 
AHNAK is expressed as a  17.5-kb RNA in a variety of 
cells. Among human cell lines examined,  we have found di- 
minished  or undetectable levels of expression  in neuroblas- 
tomas, small cell lung carcinomas,  and Burkitt lymphomas 
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(7). AHNAK contains an open reading frame that could be 
translated  into a 700-kD protein product. The salient feature 
of the predicted protein product is the presence of repeated 
domains comprising almost 80% of its amino acid sequence. 
Approximately 4,300 amino acids in the middle portion of 
the protein are arranged  in multiple  repeats  of a sequence 
motif of 128 amino acids. Some of the repeats have internal 
deletions which occur at the same position.  The degree of 
amino acid identity between any two of the repeats is at least 
80% and practically all the sequence differences are conser- 
vative (7). 
Examination  of amino acid sequence within the repeated 
domain has revealed redundancy  at a different level: heptad 
repeats with a proline residue in the seventh position.  The 
character  of each  heptad  could  be  best  represented  as 
~+~P+~+  where  ~  is  a  hydrophobic  residue,  +  is  a 
charged residue, and P is proline. We proposed that AHNAK 
protein has an unprecedented secondary structure resem- 
bling  a/3-strand and distinct  in that  it has a periodicity of 
2.33,  i.e., three turns of the carbon backbone every seven 
residues (7).  This structure segregates  the hydrophllic  and 
hydrophobic  residues to opposing sides of the polypeptide 
chain.  We have also proposed that seven or eight of these 
molecules could interact through their hydrophobic surfaces 
to form an extremely long (,~1.2 t~) and thin  (9.8 or 10A*) 
barrel (7). Thus, AHNAK appears to represent a previously 
unidentified  type of fibrous protein.  As a first step towards 
discerning  the  function  of AHNAK  we  have  developed 
specific antibodies for the AHNAK protein, and then used 
these to show that the protein resides in the nucleus and is 
pbospborylated on  serine  and  threonine,  particularly  in 
proliferating  cells. 
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Preparation of  Antisera 
The chemically synthesized  peptides  CKISMPDVDLHLKGPKM  (KIS) 
and CLKMPKVKMPKFSMPGF (FEN) were used to raise specific anti- 
AHNAK sera. An additional cysteine group was added to the arninotermini 
to allow coupling of the peptides to the tuberculin  purified protein derivative 
with  m-maieidobenzoyl-N-hydroxysuccinimide  ether  as  described  (3). 
Each preparation was injected into two New Zealand rabbits under the 
auspices  of CaiTag, Inc.  (South San Francisco,  CA). 
Immunoaltinity purification of antisera was performed on columns con- 
taining  immunogenic  peptide  coupled  to  cyanogen-bromide  activated 
agarose beads as described (3). The antibodies eluted from the column were 
dialyzed against PBS and used for protein analysis without further concen- 
tration. All results reported here were obtained using these preparations of 
antibodies, which hereafter are named KIS4 and FEN2, and are derived 
from sera obtained from rabbits injected with the KIS and FEN peptides, 
respectively. 
lmmunoprecipitation and lmmunobiot Analysis 
In vivo labeling of cells for immunoprecipitation analysis  was performed 
bY35 incubation of cells in methionine-free medium containing 250 ttCi of 
[3 S]methionine per ml or in pbospbate-free medium containing 500 ttCi 
[32p]orthophosphate per mi. Protein extracts were prepared from cultured 
cells by lysis in RIPA buffer (150 mM NaC1, 20 mM Tris, pH 8.0, 5 mM 
EDTA, 0.5% NP-40, 0.5% deoxycholate,  0.5% Tween, 0.25%  SDS) or by 
lysis in a buffer containing 150 mM NaCI,  20 mM Tris,  pH 8.0, 5 mM 
EDTA, and 0.5% of NP-40. All buffers contained the following protease in- 
hibitors: PMSF at 1 mM, aprotinin at 50 ~tg/ml, leupeptin, and pepstatin 
at  10  ttg/mi  each.  The  lysates  were  clarified  by  centrifugation.  Im- 
munoprecipitations were carried out in RIPA buffer with 10 to 30 t~l of the 
immunoaffinity purified antiserum KIS4 for 2 h at 40C. After the addition 
of protein A-Sepharose,  incubation was continued for another 40 min and 
the beads were washed four times in RIPA buffer. The immunoprecipitated 
proteins were analyzed by gel electrophoresis and autoradiography. 
Cellular lysates for Western blotting were prepared by boiling pelleted 
cells in Laemmli sample buffer. Proteins separated on 4% SDS-polyacryl- 
amide gel with 3 % upper gel were transferred to nitrocellulose membranes 
in a semi-dry blotting apparatus (E & K Scientific Products, Inc., Saratoga, 
CA).  The blots were incubated 30 rain in a solution containing 150 mM 
NaCI, 5 mM KC1, 10 raM Tris-HC1, pH 7.0, 2% dry milk, 5% calf serum, 
and 0.5 % Tween. The antibody incubation was for 2 h in the same solution. 
The antigen-antibody complexes  were detected with ~25I-containing anti- 
body against rabbit IgG. 
Subcellular Fractionation 
Approximately 107 HeLa cells were washed in hypotonic buffer containing 
10 mM KCI, 10 mM Tris HCI, pH 7.4,  I mM MgC12, and protease inhibi- 
tors, and suspended in the same buffer containing 0.5% NP-40. After a 10- 
min incubation on ice, nuclei were separated from the cytoplasmic fraction 
by centrifugation  at 1,000 g for 5 rain, washed in hypotonic buffer with 0.5 % 
NP-40 and extracted in a buffer containing 150 mM NaCI. The wash frac- 
tions were combined with the cytoplasmic supernatant. Total cell lysate, nu- 
clear,  and cytoplasmic fractions were analyzed by Western blotting with 
anti-AHNAK  antibodies. 
Immunofluorescence 
Cells were grown on 12-mm coverslips for at least 24 h before processing. 
After two washes in PBS, cells were fixed in 3.75% paraformaldehyde  for 
20 min at room temperature or in methanol for 6 min at -200C. Both fixa- 
tion methods produced identical patterns of immunofluorescence.  Fixed 
cells were washed three times with PBS, permeabilized in Ab buffer (PBS, 
3% BSA, 0.1% Triton X-100)  for 20 rain, and incubated with the im- 
munoaffinlty purified serum FEN2 for 1 h. The purified antibody and whole 
serum FEN2 produced identical immunofluorescence  patterns in a variety 
of cells. Coverslips were washed with PBS and incubated for 40 min with 
the secondary antibodies (affinity-purified  rhodamine-conjugated donkey 
anti-rabbit  or  fluorescein-conjugated  sheep  anti-rabbit  (Boehringer- 
Mannheim Biochemieals,  Indianapolis,  IN) diluted  1:100 in Ab buffer. 
Staining for DNA was done by incubation with Hoechst 33258 at 5/.tg/ml 
in PBS. Coverslips were washed in PBS and mounted in Immumount (Shan- 
don Southern Instruments Inc., Sewickley, PA). Micrographs were taken 
with a  Zeiss Axiophot microscope (Carl Zeiss,  Oberkochen, Germany) 
with the X63 oil objective and Kodak T-Max 400 film (Eastman Kodak Co., 
Rochester,  NY). 
Phosphoamino Acid Analysis 
The AHNAK  protein was  immunoprecipitated from cells labeled with 
[32p]orthophosphate,  and then subjected  to electrophoresis.  The protein 
was  transferred to Immobilon-P (Millipore Continental Water  Systems, 
Bedford,  MA), the labeled band was excised, and then hydrolyzed in 6 M 
HC1 at ll0*C for 90 rain. Phospboamino acids were separated on cellulose 
thin layer plates by electrophoresis  in two dimensions (2).  The migration 
of unlabeled phosphoamino acids  was determined by ninhydrin staining, 
and radioactive  amino acids were detected by autoradiography. 
Results 
Identification of  AHNAK Protein 
To  identify  and  characterize  the  protein  product  of the 
AHNAK gene, we have raised anti-AHNAK polyclonal sera 
in rabbits. Based on the predicted amino acid sequence of 
AHNAK protein, two synthetic peptides of 17 amino acids 
each were made and used for immunizations. Both peptides 
corresponded to regions within the repeated domain of the 
predicted AHNAK polypeptide. The peptide "KIS" corre- 
sponds to the first 16 amino acids of the AHNAK 128 amino 
acids repeat (7),  while the peptide "FEN" corresponds to 
amino acids 59-74 of the repeat. 
The initial characterization  of the sera was done using por- 
tions of AHNAK protein expressed in Escherichia coli. The 
cDNA fragments  of AHNAK were cloned into appropriate 
pGEX vectors (11) to produce fusion proteins of glutathion- 
S-transferase  (GST) 1 and  AHNAK-specific polypeptides. 
Extracts from bacterial clones induced to express the fusion 
proteins were analyzed by Western blotting with the antisera 
raised against  AHNAK peptides.  We have found that  sera 
from one rabbit injected with the "KIS" peptide (designated 
KIS4) and one injected with the "FEN-" peptide (FEN2) pro- 
duced antibodies recognizing  appropriate GST-AHNAK fu- 
sion proteins (data not shown). These two antisera were fur- 
ther  examined  by Western  blot analysis  of total  protein 
extracts prepared from cells expressing or lacking AHNAK 
RNA. Fig.  1 A shows a Coomassie-stained gel containing 
electrophoretically  separated high molecular weight proteins 
from  the melanoma  cell  line  C32r  (expressing  AHNAK 
RNA) and  small  cell lung  carcinoma line  N417  (lacking 
AHNAK RNA) (7).  A very slowly migrating  protein spe- 
cies, visible at the top of the gel in the C32r extract but not 
in the N417  extract,  appears to be recognized by various 
anti-AHNAK  antisera  (FEN2 and KIS4 and the immuno- 
affinity-purified  antibodies  from  these  sera),  but not  the 
preimmune sera (Fig.  1, B-F). 
Fig.  2  shows  that  the  candidate  AHNAK protein  was 
specifically  immunoprecipitated  from extracts  of psS]me- 
thionine-labeled  cells with the immunoafllnity-purified  anti- 
body KIS4.  No protein could be immunoprecipitated  from 
cell line N417,  which lacks detectable levels of AHNAK 
RNA, or when preimmune serum was used. The interaction 
of antibodies with the protein was blocked by addition of the 
immunogenic  peptide.  The molecular weight  of AHNAK 
protein could not be estimated on the basis of its migration 
1. Abbreviation used in this paper:  GST, glutathion-S-transferase. 
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sis  of AHNAK protein  with 
polyclonal immune sera.  To- 
tal protein  extracts  (150 #g) 
from the melanoma cell line 
C32r (lanes/) and small ceil 
lung carcinoma cell line N417 
(lanes 2) were separated on a 
4% acrylamide gel.  (.4) Coo- 
massie blue stain gel.  (B-G) 
Identical Western blot strips 
containing proteins shown in 
A probed with: preimmune se- 
rum KIS4 diluted  1:200 (B); 
immune serum KIS4 diluted 
1:200  (C);  immunoaffinity- 
purified  antibodies  from the 
serum KIS4 diluted 1:100 (D); 
preimmune serum  FEN2  di- 
luted  1:100 (E); immune se- 
rum FEN2 diluted 1:100 (F); 
and  immunoaffinity-purified 
antibodies from serum FEN2 
diluted 1:10 (G). 
in the gel: the protein band appeared much higher on the gel 
than the largest molecular weight marker of 200 kD. Our es- 
timate of  the molecular weight of AHNAK protein, based on 
the length of the open reading frame of AHNAK RNA, is 
~700 kD (7). 
In further characterization of the antisera, we found that 
KIS4 recognized only the denatured form of AHNAK pro- 
tein and gave no signal in immunofluorescence. In contrast, 
FEN2 reacted with both native and denatured protein, and 
could be used in immunofluorescence. Since immunoaffin- 
ity-purified KIS4 had a significantly higher titer than FEN2, 
we used KIS4 for all analyses except immunofluorescence. 
All immunoaflinity-purified preparations of the two antisera 
appeared to have the same specificity when tested accord- 
ingly (see above). 
SubceUular Localization of  AHNAK Protein 
The antibodies raised against AHNAK protein were used to 
address the question of its subcellular localization. For con- 
venlence we analyzed HeLa cells, which are readily frac- 
tionated  into  subcellular  organelles  and  which  produce 
abundant  AHNAK protein (see below).  HeLa cells were 
fractionated into crude nuclear and cytoplasmic fractions by 
lysis in hypotonic buffer in the presence of nonionic deter- 
gent. Proteins were extracted from nuclei by 150 mM NaC1 
in the presence of 0.5% NP-40. Fig. 3 shows Western blot 
analysis of  AHNAK in the nuclear and cytoplasmic fractions 
of HeLa cells. The major portion of AHNAK protein was de- 
tected in the nuclear rather than the cytoplasmic fraction. 
Next, we used indirect immunofluorescence to examine 
the subcellular localization of AHNAK.  Fig.  4  shows  the 
Figure 2.  Immunoprecipita- 
tion of  AHNAK protein. Cells 
were labeled with [~SS]methi- 
onine and lysed in RIPA buf- 
fer. Equal amounts of protein 
extracts  (200  ~g)  were  ana- 
lyzed by immunoprecipitation 
with 20 ~1 of  the immunoaffin- 
ity-purified antibodies KIS4. 
The following ceil lines were 
analyzed: melanoma C32r (/); 
small ceil lung carcinoma  N417 
(2);  neuroblastoma  NGP (3); 
mouse  fibroblasts  NIH  3T3 
(4); NIH 3T3 with addition of 
2/~g of  the immunogenic pep- 
tide KIS  (5);  and  NIH  Yr3 
extract  immunoprecipitated 
with the preimmune serum (6). 
Figure 3. Subcellular  localiTation  of  AHNAK 
protein in HeLa ceils. Subceilular fractions 
were prepared as described in Materials and 
Methods. Proteins extracted from the equiv- 
alent of 10  ~  cells were analyzed by Western 
blotting  with  the  immunoaffinity-purified 
antiserum KIS4. T, total cell lysate; N, nu- 
clear fraction; and C, cytoplasmic fraction. 
Shtivelman and Bishop AHNAK  Protein  627 Figure  4.  Localization  of 
AHNAK protein in cultured 
cells by indirect immunofluo- 
rescence. NIH 3T3 cells (a-f) 
or Ptkl (g and h) cells were 
stained with Hcechst 33258 
(a,  c, e, and g),  preimmune 
serum (b), anti-AHNAK im- 
munoaffinity-purified serum 
FEN2 in presence (d), or ab- 
sence (land h) of the immune 
peptide followed  by secondary 
antibody conjugated  to rhoda- 
mine (b, d, and f) or fluores- 
cein (h). 
pattern of staining observed with NIH 3"1"3 cells. Specific 
staining  of proteins  in  the  nuclei  and  in  an  asymmetric 
perinuclear structure was evident with the immune antibody, 
but not with the preimmune serum or when the antibodies 
were preincubated with the immunogenic peptide (Fig. 4). 
In addition, we consistently observed a weak, diffuse cyto- 
plasmic staining. The predominantly nuclear localization of 
AHNAK protein by immunofluorescence is  in agreement 
with the results of the cell fractionations. 
The pednuclear structure stained by the antibodies resem- 
bled morphologically the Golgi apparatus. To examine this 
possibility we performed double staining of cells with FEN2 
and wheat germ agglutinin, which predominantly binds to 
the elements of the Golgi network. We observed that the 
wheat germ agglutinin and the anti-AHNAK antibody bound 
to the same perinuclear structure. Thus, it remains possible 
that AHNAK protein might be associated with the Golgi net- 
work (data not shown), but that possibility requires further 
assessment (see Discussion). 
We  have  performed  immunofluorescent localization of 
AHNAK protein in several human cells lines, including epi- 
theliai cells, melanoma and neuroblastoma cells. Indepen- 
dent of the cell line we have observed staining of nuclei and 
a  perinuclear asymmetric structure resembling the  Golgi 
network (data not shown). We have also examined the rat 
kangaroo kidney cell line Ptkt for the localization of AHNAK 
protein after confirming that the same high molecular weight 
protein could be immunoprecipitated from extracts of these 
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protein  in  growing versus 
quiescent  NIH 3"1"3  cells. (A) 2 
x  105  cells  from  actively 
proliferating (lane/) or quies- 
cent (lane 2) culture were la- 
beled with inorganic [32p] for 
2.5 h, lysed in RIPA buffer, 
and analyzed by immunopre- 
cipitation with the immunoaf- 
finity-purified KIS4 antibod- 
ies. The smear in lane I is due 
to the presence of radioactive 
DNA  in the cell lysate. (B) 
l0  s  cells  from  parallel  cul- 
tures were analyzed by West- 
ern  blotting with  antibodies 
KIS4. 
cells (data not shown). Again, we have observed immuno- 
fluorescence in the nuclei and the structure resembling the 
Golgi apparatus (Fig. 4 H). 
AHNAK Is a Phosphoprotein 
We have reported previously that the carboxyl-terminal por- 
tion of the AHNAK sequence contains several repeats of the 
sequence "lysine-serine-proline-lysine"  which is identical to 
the "DNA finger" sequences found in historic proteins (4). 
The "DNA fingers" found in histories are the sites of mitosis- 
specific phosphorylation on serine residues  (4).  We con- 
ducted experiments to determine if AHNAK protein is phos- 
phorylated and, if so, whether the modification is related to 
the cell cycle. To this end, AHNAK protein was immunopre- 
cipitated from NIH 3T3 cells after metabolic labeling with 
radioactive  inorganic  phosphate.  We  examined  actively 
growing and quiescent cells deprived of serum for 2 d. Fig. 
5  A  shows that  AHNAK protein  was phosphorylated in 
growing cells and that this phosphorylation was greatly di- 
minished in quiescent NIH 3"173 cells. In contrast, Western 
blot  analysis  demonstrated  that  quiescent  cells  contain 
higher levels of AHNAK protein (Fig. 5 B). We conclude 
that AHNAK is a phosphoprotein and that the transition of 
fibroblasts into Go is  accompanied by both accumulation 
and apparent dephosphorylation of AHNAK protein. 
We  have  performed  phosphoamino  acid  analysis  of 
AHNAK protein in actively growing NIH 3T3 ceUs and have 
determined that it is phosphorylated on serine and, to a much 
lower extent, on threonine (data not shown). Serine residues 
are found in four conserved positions within every repeat 
unit of  AHNAK (7) with occasional substitutions by threonine 
residues. The carboxy-terminal unique portion of AHNAK 
is relatively serine rich (7), while threonine residues are in- 
frequent. Tyrosine residues are found at a conserved position 
in some of the repeats of AHNAK, but no phosphorylation 
of tyrosine was observed (data not shown). Identical results 
were obtained when phosphoamino acid analysis was per- 
formed  with  AHNAK  protein  immunoprecipitated  from 
HeLa cells (data not shown). 
AHNAK Protein in Differentiating 
Neuroblastoma Cells 
AHNAK was first identified as a gene whose expression is 
lqgure 6. Effect  of differentiation  on expression of AHNAK RNA. 
Cells were treated for the periods of time indicated and total cellu- 
lar RNAs (20 #g) were analyzed for the levels of AHNAK RNA 
by RNAse protection assay of a specific riboprobe prepared with 
a 5' end fragment of AHNAK cDNA (7). The length of the pro- 
tected fragment is 330 nucleotides. The lane labeled Mel contains 
20 #g of total RNA from the melanoma cell line HT144. 
reduced in neuroblastoma cell lines in comparison to other, 
more differentiated cells of neuroectodermal origin (6, 7). 
We examined if any changes in the expression of AHNAK 
occur in differentiating  neuroblastoma cells. Neuroblastoma 
cell lines NGP and LAN5 were treated with retinoic acid to 
induce neuronal differentiation (8) and analyzed for the lev- 
els of AHNAK RNA over the course of treatment. In both 
cell lines we observed an increase in the levels of AHNAK 
RNA after 1-2 d of exposure to retinoic acid, after which the 
levels of AHNAK RNA remained unchanged (Fig. 6). The 
long interval between application of retinoic acid and the in- 
duction of AHNAK RNA most likely indicates that the latter 
is an indirect consequence of more immediate changes in- 
duced by retinoic acid. The timing of AHNAK RNA induc- 
tion in neuroblastoma cells coincides with the cessation of 
cellular  division  and  the  appearance  of  morphological 
changes in the transformed neuroblasts (8, 9). 
Next  we  analyzed  the  levels  and  phosphorylation  of 
AHNAK protein in untreated versus differentiating neuro- 
blastoma cells (Fig. 7). AHNAK protein labeled with radio- 
active phosphate was precipitated from untreated cells of 
neuroblastoma NGP and after treatment with retinoic acid 
for 2 d. Fig. 7 (A and B) shows that the phosphate content 
of AHNAK protein in differentiating cells was diminished, 
whereas the levels of the protein increased. Similar results 
were obtained with the neuroblastoma cell line LAN5 (data 
not shown). The levels of AHNAK remained elevated for up 
to 7 d after the beginning of the treatment (Fig. 7  C). 
Discussion 
The Size of  AHNAK Protein 
As predicted from nucleotide sequence (7), AHNAK protein 
isolated from cells appears to be exceptionally large. The 
data presented here do not permit a reliable assessment of 
size  because  large  proteins  may migrate anomalously in 
Shtivelman and Bishop AHNAK  Protein  629 Figure 7. Effect of differentia- 
tion on expression and phos- 
phorylation of AHNAK pro- 
tein.  (.4) NGP  cells  were 
treated with 5 izM of retinoic 
acid for 48 h. 2  x  105 cells 
from  untreated (lane NGP) 
and treated with retinoic acid 
culture  (lane NGP  +  RA) 
were labeled with  inorganic 
[32p] for 2.5 h, lysed in RIPA 
buffer, and analyzed  by immu- 
noprecipitation with the  im- 
munoaffinity purified  serum 
KIS4. (B) 2 ￿  lit cells from 
parallel  cultures were ana- 
lyzed by Western  blotting with 
antibodies KIS4. (C) Western 
blot analysis  of  protein lysates 
(100 t~g of protein per lane) 
prepared  from  NGP  ceils 
treated with retinoic acid for 
the periods of time indicated. 
polyacrylamide gels. Thus, we continue to use the estimate 
of 700 kD for the mass of the protein, based on the deduced 
amino acid  sequence.  The  representation  of AHNAK in 
cDNAs still suffers from two apparently small gaps, but the 
corresponding regions of the genomic DNA have been se- 
quenced and found to contain open reading frames that are 
continuous with the open reading frame represented in the 
adjoining cDNAs (7). It seems likely that we have the entire 
coding domain for AHNAK in view. We consider it unlikely 
that the gene produces a second protein by means of alterna- 
tive splicing, since no introns are apparent in the nucleotide 
sequence of AHNAK (7).  Therefore, we conclude that the 
protein identified  here with two distinctive antisera and in di- 
verse cell lines is the principal or sole product of AHNAK. 
The SubceUular Location of  AHNAK Protein 
Our results indicate that the bulk of AHNAK protein is lo- 
cated in the nucleus. How can a protein with a mass of 700 
kD gain access to the nucleus? Two properties of  the AHNAK 
proteins may provide an explanation. First, the rodlike struc- 
ture  conjectured  for  the  protein  may  facilitate  passage 
through the confining diameter of  nuclear pores. Second, the 
carboxy-terminal domain of  the protein contains several pos- 
sible nuclear localization signals that might facilitate nuclear 
transport by increasing the efficiency  of interaction with pro- 
teins that bind the nuclear localization signals (10). 
Several features of the AHNAK protein suggest that it may 
have a role in the architecture of the nucleus. First, the pro- 
tein is both relatively stable (data not shown) and abundant 
(Fig.  1 A). Second, molecular modeling predicts a remark- 
ably elongated and rigid tertiary structure (7). And third, our 
preliminary results indicate that the protein might bind DNA 
in a nonspecific manner (data not shown). These properties 
cause one to think of the nuclear matrix or scaffolding (1, 5), 
but the AHNAK protein is too readily extractable from the 
nucleus to be considered a component of  these structures. In- 
stead,  the decidedly hydrophilic surface of the projected 
structure suggests that the protein could easily reside in the 
nucleoplasm. Moreover, it is possible that the two terminal 
domains of the protein (which are not part of the fibrous 
structure) could have functions of their own that are not of 
an architectural nature. 
The nuclear staining of  AHNAK protein was mainly punc- 
tate, an observation that seems at odds with the predicted 
structure for the protein. Given the denaturation that accom- 
panies fixation, however, it seems unreasonable to expect the 
pattern of staining to necessarily reflect the native structure 
of the protein. Examination by immunoelectron microscopy 
might be more revealing. 
Analysis by immunofluorescence indicated that a minor 
fraction of AHNAK protein  may be  associated  with the 
Golgi network.  The protein displays no structural feature 
that would either predict or explain sequestration in a mem- 
branous organelle. Our preliminary data from subcellular 
fractionations confirm that the cytoplasmic AHNAK protein 
is confined to the membrane-containing fraction, but further 
work will be required to determine whether the protein does 
in reality reside in the Golgi apparatus. 
Modifications  of the AHNAK Protein During Changes 
in Cellular Proliferation  and Differentiation 
The product of AHNAK is phosphorylated on serine and 
threonine.  Both amino acids are abundant throughout the 
protein, but the particular residues subject to phosphoryla- 
tion and the responsible kinase(s) are not known. The phos- 
phorylation appears to decrease substantially when ceils are 
rendered quiescent. It is conceivable that this decrease is due 
to limitations of isotopic labeling in quiescent cells, but we 
note that the decrease  was  observed  with cells  rendered 
quiescent by either deprivation of serum  or induction of 
differentiation in  rich  growth  medium.  By  contrast,  the 
abundance of AHNAK protein increases appreciably in the 
Go stage of the cell cycle, as if the protein might have an es- 
pecially prominent function in quiescent cells. Perhaps de- 
phosphorylation is a correlate of that function. 
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